Observe Medical receives follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market

The follow-up order represents a value of 4.2 mSEK, with planned delivery of the products during Q3 this year. The original order, with a value of 5.8 mSEK was announced on January 29. Thus, the total order value is 10 mSEK with potential for yet additional follow-up orders later in 2021.

“It’s highly rewarding to receive this follow-up order, and especially motivating to again be able to source the products through our excellent supplier relations, in the currently critically constrained global supply situation. Thereby we are supporting the healthcare system with the safety needles which are important tools for the healthcare providers during the current pandemic,” says Anders Nachtweij, Sales Director, Observe Medical.

“This order further validates our sales team professionalism and strong customer relations. It strengthens our full product portfolio and specifically facilitates the access to the target customers for Sippi®, currently launched in the Nordic market and selected European countries,” says Björn Larsson, CEO of Observe Medical.

The revenue from the follow-up order is expected to be included in Q3 2021 financial reporting of Observe Medical.